Rubella virus-associated uveitis: The essentiality of aqueous humor virological analysis.


Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 15 3 2022
medline: 4 10 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

Rubella virus-associated uveitis (RVAU) classically presents with the clinical features of Fuchs uveitis syndrome (FUS). We report a series RVAU, and discuss the relevance of available diagnostic strategies, and how vaccination could potentially prevent disease. We retrospectively included patients with RV-positive aqueous humor (AH) with RT-PCR and/or intraocular RV-IgG production, between January 2014 and December 2019. RV-IgG titers from AH and serum were compared with other virus-specific IgG titers (VZV and/or CMV and/or HSV-1), to determine the derived Goldmann-Witmer coefficient (GWC'). Clinical findings at presentation and during follow-up are reported, as well as the anti-RV vaccination status. All 13 included patients demonstrated intraocular synthesis of RV-IgG (median GWC': 9.5; 3.2-100). RV-RNA was detected in one patient while PCR results were negative for other HSV1, VZV and CMV. The mean delay in diagnosis was 13 ± 12.6 years, with an initial presentation of FUS in only 3 patients (23%). Only four patients had been vaccinated, but all after the recommended age. As RVAU is a pleiomorphic entity, virological analysis (RV RT-PCR and GWC') of aqueous humor is essential to improve the diagnosis and management of this entity. Improper vaccination against RV appears to be implicated in RVAU.

Sections du résumé

AIMS / BACKGROUND UNASSIGNED
Rubella virus-associated uveitis (RVAU) classically presents with the clinical features of Fuchs uveitis syndrome (FUS). We report a series RVAU, and discuss the relevance of available diagnostic strategies, and how vaccination could potentially prevent disease.
METHODS METHODS
We retrospectively included patients with RV-positive aqueous humor (AH) with RT-PCR and/or intraocular RV-IgG production, between January 2014 and December 2019. RV-IgG titers from AH and serum were compared with other virus-specific IgG titers (VZV and/or CMV and/or HSV-1), to determine the derived Goldmann-Witmer coefficient (GWC'). Clinical findings at presentation and during follow-up are reported, as well as the anti-RV vaccination status.
RESULTS RESULTS
All 13 included patients demonstrated intraocular synthesis of RV-IgG (median GWC': 9.5; 3.2-100). RV-RNA was detected in one patient while PCR results were negative for other HSV1, VZV and CMV. The mean delay in diagnosis was 13 ± 12.6 years, with an initial presentation of FUS in only 3 patients (23%). Only four patients had been vaccinated, but all after the recommended age.
CONCLUSION CONCLUSIONS
As RVAU is a pleiomorphic entity, virological analysis (RV RT-PCR and GWC') of aqueous humor is essential to improve the diagnosis and management of this entity. Improper vaccination against RV appears to be implicated in RVAU.

Identifiants

pubmed: 35285294
doi: 10.1177/11206721221087562
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0
RNA 63231-63-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3489-3497

Auteurs

Julien Provost (J)

Department of Ophthalmology, Bicêtre Hospital, 26930Assistance Publique - Hôpitaux de Paris, Paris-Saclay University, France.

Marc Labetoulle (M)

Department of Ophthalmology, Bicêtre Hospital, 26930Assistance Publique - Hôpitaux de Paris, Paris-Saclay University, & U1184, IMVA-HB, CEA, France.

Elise Bouthry (E)

Department of Virology, Hôpital Paul Brousse, 26930Assistance Publique - Hôpitaux de Paris, Paris-Saclay University, INSERM U1193, France.

Oscar Haigh (O)

Department of Immunology of Viral, Auto-immune bacterial and hematological Diseases, U1184, IMVA-HB, CEA, France.

Igor Leleu (I)

Department of Ophthalmology, 55862Centre Hospitalier National d'Ophtalmologie des XV-XX, France.

Alfred Kobal (A)

Department of Ophthalmology, 55862Centre Hospitalier National d'Ophtalmologie des XV-XX, France.

Frédéric Mouriaux (F)

Department of Ophthalmology, Rennes University Hospital, Rennes, France.

Emmanuel Barreau (E)

Department of Ophthalmology, Bicêtre Hospital, 26930Assistance Publique - Hôpitaux de Paris, Paris-Saclay University, France.

Christelle Vauloup-Fellous (C)

Department of Virology, Hôpital Paul Brousse, 26930Assistance Publique - Hôpitaux de Paris, Paris-Saclay University, INSERM U1193, France.

Antoine Rousseau (A)

Department of Ophthalmology, Bicêtre Hospital, 26930Assistance Publique - Hôpitaux de Paris, Paris-Saclay University, & U1184, IMVA-HB, CEA, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH